JONATHAN SPORN

Aight, so peep Jonathan Sporn. This guy’s the real deal in the biotech and psychedelics space. So, he came up through the YC S20 batch, which, if you know YC, means he’s legit, got that startup grind and hustle. But what’s crazy is his focus: psychedelics and neuroscience, which is still kinda niche but super hot right now.

Before YC, he was already deep into the scene. He worked at Gilgamesh Pharmaceuticals, a clinical-stage biotech company, and also did some serious stuff at Perception Neuroscience. Basically, he’s been around the science and startup game, trying to crack how psychedelics can actually help people, not just some hype, but real medicine. Gilgamesh, for example, closed a $27 million Series A, which is no joke, that’s big money, and it shows they’re legit and moving fast.

What’s wild is how he’s jumped into this intersection of science, mental health, and startup hustle. His process says a lot about his motivation, dude’s not just in it for the tech fame; he genuinely wants to change how we treat mental health problems using psychedelics. That’s some advanced stuff, and he’s already making waves. His experience at YC, especially coming from a science background, shows he’s got the brains and the guts to turn these ideas into real-world solutions.

Basically, Jonathan’s story is about someone who saw the bullshit in traditional mental health treatments, got curious about psychedelics, and then decided to build companies that could actually make a difference. He’s the kind of guy who’s not afraid to jump into uncharted waters, and his track record proves he’s crushing it. If you ask me, he’s one of the few pushing the frontier of biotech and psychedelics, and he’s doing it with serious science and startup fire. No Cap, this guy’s gonna be a major player in the future of mental health tech.